Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2020 - 2021)

Lexaria Bioscience's Other Non-Current Liabilities history spans 2 years, with the latest figure at $49989.0 for Q3 2021.

  • Quarterly results put Other Non-Current Liabilities at $49989.0 for Q3 2021, down 44.08% from a year ago — trailing twelve months through Aug 2021 was $49989.0 (down 44.08% YoY), and the annual figure for FY2021 was $49989.0, down 44.08%.
  • Other Non-Current Liabilities for Q3 2021 was $49989.0 at Lexaria Bioscience, down from $89393.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $89393.0 in Q3 2020 to a low of $49989.0 in Q3 2021.